Information Provided By:
Fly News Breaks for April 24, 2015
AERI
Apr 24, 2015 | 14:31 EDT
Needham downgraded Aerie Pharmaceuticals to Hold citing uncertainty after Rhopressa missed the primary endpoint in a Phase 3 trial.
News For AERI From the Last 2 Days
There are no results for your query AERI